Head-To-Head Review: Hybrid Energy (OTCMKTS:HYBE) versus Nephros (NASDAQ:NEPH)

Nephros (NASDAQ:NEPH) and Hybrid Energy (OTCMKTS:HYBE) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, profitability, institutional ownership, valuation, dividends, analyst recommendations and risk.

Profitability

This table compares Nephros and Hybrid Energy’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nephros	6.35%	12.22%	9.38%
Hybrid Energy	N/A	N/A	N/A

Risk & Volatility

Nephros has a beta of 1.42, suggesting that its share price is 42% more volatile than the S&P 500. Comparatively, Hybrid Energy has a beta of 1.64, suggesting that its share price is 64% more volatile than the S&P 500.

Valuation & Earnings

This table compares Nephros and Hybrid Energy”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nephros	$18.79 million	1.70	$1.19 million	$0.11	27.27
Hybrid Energy	N/A	N/A	N/A	N/A	N/A

Nephros has higher revenue and earnings than Hybrid Energy.

Institutional and Insider Ownership

41.1% of Nephros shares are owned by institutional investors. 6.7% of Nephros shares are owned by insiders. Comparatively, 6.0% of Hybrid Energy shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of recent ratings for Nephros and Hybrid Energy, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nephros	0	1	1	0	2.50
Hybrid Energy	0	0	0	0	0.00

Nephros currently has a consensus target price of $6.00, indicating a potential upside of 100.00%. Given Nephros’ stronger consensus rating and higher probable upside, analysts plainly believe Nephros is more favorable than Hybrid Energy.

Summary

Nephros beats Hybrid Energy on 9 of the 10 factors compared between the two stocks.

About Nephros

Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

About Hybrid Energy

Hybrid Energy Holdings, Inc., through its subsidiaries, acquires and operates fuel production and other energy companies. It acquires companies with traditional and proven fuel production, photovoltaic (PV) and solar thermal technologies. Hybrid Energy Holdings, Inc. was formerly known as Comprehensive Healthcare Solutions, Inc. and changed its name to Hybrid Energy Holdings, Inc. in September 2009. Hybrid Energy Holdings, Inc. was incorporated in 1966 and is based in Reno, Nevada. Hybrid Energy Holdings, Inc. is in reorganization.